Similar Articles
1241 Liver transplantation for hepatocellular carcinoma: Where do we stand?
1242 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
1243 Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis
1244 Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
1245 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
1246 Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma
1247 Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
1248 Mechanisms of hepatocellular carcinoma progression
1249 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
1250 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA